Plain-English translation of NCT07382414 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Denmark
Sponsor
Tor Biering-Sørensen
Collaborators
Novartis
Enrollment target
~123,000 participants
Started
September 2026
Primary completion
September 2031
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tor Biering-Sørensen, MD, MPH, MSc, PhD
Tor Biering-Sørensen
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.